Mounjaro® (Tirzepatide) Injection 7.5 mg/0.5 mL – Prefilled Syringes (4-Pack, RX Only)

Description

Mounjaro® (Tirzepatide) Injection 7.5 mg/0.5 mL – Prefilled Syringes (4-Pack, RX Only). By activating both GLP-1 and GIP receptors, Mounjaro helps increase insulin release when blood sugar levels are elevated, reduce glucagon secretion, and slow the emptying of food from the stomach. These effects help improve overall blood sugar stability and may also contribute to appetite reduction and weight loss in patients with type 2 diabetes.

The 7.5 mg dose is typically prescribed as part of a gradual dose-titration plan for patients who have adjusted to lower strengths and require additional glycemic control. Each carton contains four single-use, prefilled syringes, with one injection administered per week. Mounjaro is injected just under the skin and is designed for convenient at-home use when prescribed by a licensed healthcare provider.

Mounjaro is not insulin and is not intended for the treatment of type 1 diabetes. For best results, it should be used alongside a healthy diet, regular physical activity, and ongoing medical supervision.

How Mounjaro Is Used

Mounjaro is administered once weekly, on the same day each week, as a subcutaneous injection into the abdomen, thigh, or upper arm. Injection sites should be rotated to help reduce skin irritation. Before use, the syringe should be inspected to ensure the solution is clear and the medication has not expired.

After cleaning the injection site with an alcohol swab, the syringe is injected as directed. Each syringe is intended for single use only and must be disposed of in an approved sharps container after injection.

If a dose is missed, it may be taken as soon as remembered, provided the next scheduled dose is at least three days away. Patients should not take two doses within the same week unless instructed by their healthcare provider.

Unused Mounjaro syringes must be stored in the refrigerator and should never be frozen.

Important Medical Information

Mounjaro is available by prescription only and should be used exactly as directed by a healthcare professional. Blood sugar levels should be monitored regularly, and any side effects or concerns should be discussed with a licensed provider. Your healthcare provider will determine whether tirzepatide is appropriate for your diabetes treatment or medical weight loss plan.

---

What Makes Mounjaro Different?

Unlike traditional GLP-1 medications, Mounjaro activates both GLP-1 and GIP receptors, two hormones that work together to regulate insulin secretion, glucose metabolism, and appetite. This dual-action approach helps improve insulin sensitivity and overall metabolic control, making tirzepatide a leading option in modern diabetes care and physician-guided weight management programs.